Huons Co., Ltd. (KOSDAQ:243070)

Market Cap	353.17B
Revenue (ttm)	588.31B
Net Income (ttm)	31.88B
Shares Out	11.69M
EPS (ttm)	2,627.14
PE Ratio	11.50
Forward PE	n/a
Dividend	630.00 (2.09%)
Ex-Dividend Date	Jun 27, 2025

Volume	27,996
Average Volume	30,839
Open	30,550
Previous Close	30,600
Day's Range	30,200 - 30,800
52-Week Range	21,800 - 33,300
Beta	0.26
RSI	62.00
Earnings Date	Aug 14, 2025

About Huons

Huons Co., Ltd. provides medical solutions for human health in Korea and internationally. The company offers oral solid form drugs, including circulatory system, metabolic, antipyretic, analgesic, anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, and other chemotherapeutic products; and injection products, such as anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistamine, circulatory system, respiratory sy...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1965
• Employees: 912
• Stock Exchange: KOSDAQ
• Ticker Symbol: 243070

Financial Performance

In 2024, Huons's revenue was 590.23 billion, an increase of 6.92% compared to the previous year's 552.01 billion. Earnings were 29.45 billion, a decrease of -41.64%.